| Literature DB >> 33061649 |
Alice Kongsted1,2, Orla Lund Nielsen1, Henrik Wulff Christensen1, Jan Hartvigsen1,2, Klaus Doktor1,2, Peter Kent2,3, Tue Secher Jensen1,2,4.
Abstract
BACKGROUND: Back pain is among the most frequent reasons for care seeking globally. Observational clinical cohorts are useful for understanding why people seek care, the content of that care, and factors related to prognosis. This paper describes the Danish Chiropractic low back pain Cohort (ChiCo) and summarizes the primary characteristics of the population to inform the scientific community of the availability of these data as a resource for collaborative research projects.Entities:
Keywords: chiropractic; cohort studies; low back pain; primary care
Year: 2020 PMID: 33061649 PMCID: PMC7537847 DOI: 10.2147/CLEP.S266220
Source DB: PubMed Journal: Clin Epidemiol ISSN: 1179-1349 Impact factor: 4.790
Figure 1Flowchart.
Response Times for Completed Questionnaires
| Response Times | Baseline 2 (N=2029) | 2 Weeks (N=1989) | 3 Months (N=1705) | 12 Months (N=1459) |
|---|---|---|---|---|
| Mean (SD); days after distribution | 2.3 (3.8) | 2.9 (5.3) | 7.2 (10.6) | 10.8 (20.5) |
| Median (IQR); days after distribution | 1 (0–3) | 1 (0–4) | 3 (0–8) | 4 (0–9) |
| Late response; n (%)* | 105 (5.2%) | 219 (11.0%) | 78 (4.6%) | 138 (9.5%) |
Notes: *>7 days after distribution for baseline and 2 weeks follow-up; >1 month after distribution for 3 and 12 months follow-ups.
Participant Characteristics
| Participant Characteristics | Baseline | 2 Weeks | 3 Months | 12 Months |
|---|---|---|---|---|
| Age; mean (SD, full range) | 44.6 (13.7; 18–87) | |||
| Sex, female; n (%) | 1167 (41.0%) | |||
| BMI; mean (SD) | 26.9 (5.0) | |||
| Smoker, yes; n (%) | 336 (16.2%) | |||
| Longest education: | ||||
| Higher or further education; n (%) | 1040 (51.5%) | |||
| Vocational education; n (%) | 594 (29.4%) | |||
| No qualifying education; n (%) | 313 (15.5%) | |||
| Other education; n (%) | 74 (3.7%) | |||
| Employment, yes; n (%) | 2287 (82.2%) | |||
| Previous treatment for low back pain, yes; n (%) | 1357 (66.4%) | |||
| Previous episodes with low back pain, yes; n (%) | 1652 (83.3%) | |||
| Days with low back pain within past year, >30 days; n (%) | 752 (37.5%) | |||
| Episode duration: | ||||
| 1–7 days; n (%) | 1328 (47.0%) | |||
| 1 week - 3 months; n (%) | 1006 (35.6%) | |||
| >3 months; n (%) | 494 (17.5%) | |||
| STarT Back Tool risk groups | ||||
| Low; n (%) | 1211 (42.5%) | |||
| Medium; n (%) | 1014 (35.6%) | |||
| High; n (%) | 623 (21.9%) | |||
| Current use of over the counter and/or prescribed pain killers for back pain, yes; n (%) | 1041 (51.0%) | |||
| Fear-Avoidance, FABQ Work subscale (0–42); mean (SD) | 12.6 (9.4) | |||
| Days off sick within past 3 months; median (IQR) | 0 (0–1) | |||
| Present sick leave, yes; n (%) | 74 (4.8%) | 43 (2.3%) | 25 (1.3%) | 20 (1.1%) |
| Back pain intensity, NRS (0–10); mean (SD) | 6.7 (2.1) | 3.7 (2.3) | 2.3 (2.3) | 2.3 (2.4) |
| Leg pain intensity, NRS (0–10); mean (SD) | 3.0 (2.9) | 1.9 (2.4) | 1.3 (2.1) | 1.1 (2.0) |
| Back Beliefs, BBQ (9–45); mean (SD) | 32.2 (5.9) | 32.8 (6.2) | 32.0 (6.0) | |
| Activity limitation, RMDQ (0–100); mean (SD) | 55.0 (23.8) | 30.3 (26.1) | 19.7 (23.5) | 20.0 (22.8) |
| Clinician reported working diagnosis | ||||
| Non-specific LBP; n (%) | 2372 (84.7%) | |||
| Back related leg pain WITHOUT nerve root involvement; n (%) | 665 (23.8%) | |||
| Back related leg pain WITH nerve root involvement; n (%) | 164 (5.9%) | |||
| Fracture; n (%) | 14 (0.5%) | |||
| Initial suspicion of systemic pathology (Cancer, Cauda equina syndrome, Inflammatory rheumatoid arthritis, Infection)*; n (%) | 31 (1.1%) |
Note: *Participants not excluded because pathology not confirmed.
Characteristics at Baseline 1 of Responders and Non-Responders to Baseline 2 and 2-Weeks Follow-Up
| Patient Characteristics at Baseline* | Baseline 2 | 2 Weeks | ||
|---|---|---|---|---|
| Responders (N=2083) | Non-Responders (N=765) | Responders (N=2023) | Non-Responders (N=825) | |
| Age; mean (SD) | 46.1 (13.5) (n=2083) | 40.5 (13.4) (n=765) | 46.6 (13.4) (n=2023) | 39.6 (13.1) (n=825) |
| Sex, female; n (%) | 918 (44.1%) (n=2083) | 249 (32.6%) (n=765) | 872 (43.1%) (n=2023) | 295 (35.8%) (n=825) |
| Episode duration, >7 days; n (%) | 1109 (53.6%) (n=2070) | 391 (51.6%) (n=758) | 1078 (53.6%) (n=2011) | 422 (51.7%) (n=817) |
| Back pain intensity, NRS (0–10); mean (SD) | 6.7 (2.0) (n=2042) | 6.6 (2.2) (n=749) | 6.7 (2.0) (n=1987) | 6.7 (2.1) (n=804) |
| Leg pain intensity, NRS (0–10); mean (SD) | 3.0 (2.9) (n=2039) | 2.7 (2.8) (n=744) | 3.0 (2.9) (n=1980) | 2.9 (2.9) (n=803) |
| FABQ work subscale (0–42) | 12.2 (9.2) (n=1715) | 13.7 (10.0) (n=636) | 12.2 (9.1) (n=1650) | 13.7 (10.1) (n=701) |
| Activity limitation, RMDQ (0–100) | 55.4 (23.6) (n=2083) | 53.6 (24.5) (n=765) | 55.0 (23.5) (n=2023) | 54.8 (24.8) (n=825) |
| Use of medication, yes; n (%) | 1041 (51.0%) (n=2043) | N/A | 924 (51.4%) (n=1797) | 117 (47.6%) (n=246) |
Note: *All except medication are from Baseline 1.
Baseline Characteristics of Responders to Questionnaires, Participants Interviewed and Non-Responders at 3- and 12-Month Follow-Ups
| Patient Characteristics at Baseline* | 3 Months | 12 Months | ||||
|---|---|---|---|---|---|---|
| Responders to Questionnaires (N=1725) | Interviewed (N=201) | Non-Responders (N=922) | Responders to Questionnaires (N=1486) | Interviewed (N=329) | Non-Responders (N=1033) | |
| Age; mean (SD) | 47.3 (13.3) (n=1725) | 40.6 (12.5) (n=201) | 40.3 (13.4) (n=922) | 47.3 (13.0) (n=1486) | 41.5 (13.1) (n=329) | 41.6 (14.0) (n=1033) |
| Sex, female; n (%) | 746 (43.3%) (n=1725) | 60 (29.9%) (n=201) | 361 (39.2%) (n=922) | 636 (42.8%) (n=1486) | 124 (37.7%) (n=329) | 407 (39.4%) (n=1033) |
| Episode duration, >7 days; n (%) | 911 (53.2%) (n=1714) | 108 (54.0%) (n=200) | 481 (52.6%) (n=914) | 787 (53.2%) (n=1478) | 174 (53.2%) (n=327) | 539 (52.7%) (n=1023) |
| Use of medication, yes; n (%) | 805 (52.0%) (n=1547) | 43 (43.0%) (n=100) | 193 (48.7%) (n=396) | 694 (51.7%) (n=1343) | 98 (49.2%) (n=199) | 249 (49.7%) (n=501) |
| Back pain intensity, NRS (0–10); mean (SD) | 6.7 (2.0) (n=1695) | 6.7 (2.1) (n=200) | 6.7 (2.1) (n=896) | 6.6 (2.0) (n=1461) | 6.7 (2.1) (n=320) | 6.7 (2.1) (n=1010) |
| Leg pain intensity, NRS (0–10); mean (SD) | 3.0 (3.0) (n=1700) | 3.0 (2.7) (n=194) | 2.9 (2.9) (n=889) | 2.9 (2.9) (n=1466) | 3.1 (2.9) (n=321) | 3.0 (2.9) (n=996) |
| FABQ work subscale (0–42) | 12.0 (9.0) (n=1417) | 13.4 (9.4) (n=171) | 13.6 (10.2) (n=763) | 11.8 (8.9) (n=1243) | 14.2 (10.5) (n=260) | 13.3 (9.7) (n=848) |
| Activity limitation, RMDQ (0–100) | 54.8 (23.2) (n=1725) | 56.9 (25.1) (n=201) | 54.8 (24.7) (n=922) | 54.7 (23.2) (n=1486) | 56.0 (24.2) (n=329) | 55.0 (24.6) (n=1033) |
Note: *All except medication are from Baseline 1.
Outcomes at Follow-Ups for Responders, Interviewed Participants and Non-Responders at 3- and 12-Month Follow-Ups
| Patient Characteristics | 3 Months | 12 Months | ||||
|---|---|---|---|---|---|---|
| Responders to Questionnaires (N=1725) | Interviewed (N=201) | Non-Responders (N=922) | Responders to Questionnaires (N=1486) | Interviewed (N=329) | Non-Responders (N=1033) | |
| Back pain intensity at 2 weeks FU, NRS (0-10); mean (SD) | 3.7 (2.3) | 3.6 (2.3) | 3.8 (2.3) | 3.7 (2.3) | 3.9 (2.4) | 3.8 (2.3) |
| Leg pain intensity at 2 weeks FU, NRS (0-10); mean (SD) | 1.9 (2.4) | 1.7 (2.1) | 2.0 (2.5) | 1.8 (2.3) | 2.2 (2.6) | 2.0 (2.5) |
| Back pain intensity at 3 months FU, NRS (0-10); mean (SD) | 2.3 (2.3) | 2.1 (2.5) | N/A | 2.3 (2.2) | 2.3 (2.5) | 2.6 (2.4) |
| Leg pain intensity at 3 months FU, NRS (0-10); mean (SD) | 1.3 (2.1) | 1.0 (2.1) | N/A | 1.3 (2.0) | 1.2 (2.2) | 1.5 (2.2) |
| Back pain intensity at 12 months FU, NRS (0-10); mean (SD) | 2.3 (2.4) | 2.0 (2.3) | 2.4 (2.5) | 2.3 (2.4) | 2.1 (2.6) | N/A |
| Leg pain intensity at 12 months FU, NRS (0-10); mean (SD) | 1.1 (2.0) | 0.8 (1.9) | 1.2 (2.1) | 1.2 (1.9) | 0.9 (2.2) | N/A |